Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Volumn 12, Issue 10, 2006, Pages 1085-1091

  Banna, Giuseppe Luigi ^a   De Giorgi, Ugo ^a   Ferrari, Benvenuto ^a   Castagna, Luca ^a   Alloisio, Marco ^a   Marangolo, Maurizio ^a   Rosti, Giovanni ^a   Santoro, Armando ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BEP PROTOCOL; BLEOMYCIN; CCE PROTOCOL; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; ICE PROTOCOL 1; IFOSFAMIDE;

ADULT; ARTICLE; AUTOTRANSPLANTATION; CLINICAL TRIAL; DISEASE COURSE; DISEASE FREE SURVIVAL; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LUNG TUMOR; MALE; MEDIASTINUM TUMOR; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEOPLASM; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROSPECTIVE STUDY; REMISSION; SALVAGE THERAPY; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ETOPOSIDE; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROSPECTIVE STUDIES; REMISSION INDUCTION; SALVAGE THERAPY; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 39049178444     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.06.008     Document Type: Article

References (0)